The FDA has approved GSK's Arexvy for adults aged 18 to 49 who have increased risk of complications from the virus.
So far this season, 101 children have died of flu, roughly 85% of whom were unvaccinated.
A total of 90 US children have died from flu-related complications this season, according to the latest CDC update.
Children under 2 hospitalized for COVID-19 are more likely to die or become seriously ill than babies with RSV, according to a new study.
An Italian study finds an RSV-positive rapid antigen test in children aged 9 to 36 months was associated with a 48% reduced risk of receiving an antibiotic.
RSV was associated with 190,000 to 350,000 hospitalizations from July 1, 2024, to June 30, 2025, as well as 10,000 to 23,000 deaths, according to new CDC data.
The American College of Physicians recommends adults age 75 and older receive 1 dose of RSV vaccine.
Levels of RSV also remain high in many areas of the US, while COVID-19 activity is waning in most of the country.
So far this season, the CDC estimates that there have been at least 24 million flu-related illnesses, 310,000 hospitalizations, and 20,000 deaths.
Estimates didn’t differ substantially between immune-compromised and not–immune-compromised adults.